Verdence Capital Advisors LLC Pacific Biosciences Of California, Inc. Transaction History
Verdence Capital Advisors LLC
- $1.63 Billion
- Q4 2025
A detailed history of Verdence Capital Advisors LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 10,415 shares of PACB stock, worth $16,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,415Holding current value
$16,768% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
245Shares Held
189MCall Options Held
1.28MPut Options Held
601K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl30.9MShares$49.8 Million0.28% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$38 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$32.9 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$27.4 Million0.0% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V810.7MShares$17.2 Million0.21% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $362M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...